跳至主要内容
临床试验/NCT02909946
NCT02909946已完成不适用

Pathway From Functional Disability to Antimicrobial Resistance in Nursing Home Residents

University of Michigan2 个研究点 分布在 1 个国家目标入组 246 人开始时间: 2016年9月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
246
试验地点
2
主要终点
Prevalence density of multidrug-resistant organisms (MDRO)

研究概览

简要总结

Multidrug-resistant organisms (MDROs) are endemic in nursing homes (NHs) with prevalence rates surpassing those in hospitals. The aim of the study is to design and evaluate the effectiveness of a multi-component intervention to reduce new acquisition of MDROs in NH residents. The intervention will incorporate resident-level, environmental, and caregiver based strategies. Using a cluster-randomized study design, three NHs will be randomized to the intervention group and three to the control group. Control NHs will be allowed to continue standard infection prevention practices. Nursing homes will serve as the unit of allocation. Analyses will be performed both at the resident and the cluster level. The primary outcomes of the study are reduction in MDRO prevalence, and reduction in new MDRO acquisition .

详细描述

The NH intervention will incorporate resident-level, environmental, and caregiver based strategies, including: a. Standard precautions and hand hygiene for care of all residents. Enhanced barrier precautions including hand hygiene, glove use, and gown use for healthcare workers (HCW) when providing activities of daily living (ADL) assistance for residents at highest-risk (caregiver intervention); b. Hand hygiene education to residents and families (resident-level intervention); c. Standardized bathing practices including using chlorhexidine-based cloths to reduce resident MDRO colonization (resident-level intervention); d. Standardized environmental protocol and education to reduce contamination on inanimate objects and surfaces (environmental intervention); e. Feedback monthly of facility-level microbial data and new MDRO acquisition rates to infection preventionists, front-line healthcare personnel, and facility leadership (facility intervention).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 18 years old
  • Residing in a participating NH facility
  • Provided informed consent for participation

排除标准

  • Receiving end-of-life care
  • Non-English language speaking

研究组 & 干预措施

Control Arm

No Intervention

NHs randomized to the Control Arm will continue their current standard infection control practices.

Intervention Arm

Active Comparator

NHs randomized to the Intervention Arm will implement a new multi-modal infection control program.

干预措施: Multi-modal Infection Control Program (Behavioral)

结局指标

主要结局

Prevalence density of multidrug-resistant organisms (MDRO)

时间窗: From enrollment up to 6 months of study followup, or until study withdrawal (discharged from facility, at resident request, death)

Total number of MDROs isolated across all MDROs and all anatomic sites for all enrolled residents over the duration of the study period

次要结局

  • Incidence of multidrug-resistant organisms (MDRO)(From enrollment up to 6 months of study followup, or until study withdrawal (discharged from facility, at resident request, death))
  • Incidence of healthcare-associated infections(From enrollment up to 6 months of study followup, or until study withdrawal (discharged from facility, at resident request, death))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Lona Mody

Principal Investigator, Professor of Internal Medicine

University of Michigan

研究点 (2)

Loading locations...

相似试验